Blood Group Typing Market Size Poised for 9.1% CAGR, Set to Reach USD 4.18 Billion by 2033 Led by Growing Rising Blood Donations

The blood group typing market is driven by rising blood donations, increasing transfusion needs, and technological advancements in PCR-based and automated testing that enhance accuracy, efficiency, and safety in modern healthcare. As per Straits Research, the market size was valued at USD 1.91 billion in 2024 and is projected to reach USD 4.18 billion by 2033, growing at a CAGR of 9.1% during the forecast period (2025-2033).

Explore more blood group typing market report overview: https://straitsresearch.com/report/blood-group-typing-market

Blood Group Typing Market Growth Driver

One of the key drivers of the blood group typing market is the increasing volume of blood donations and transfusion procedures worldwide. Voluntary blood donations have risen significantly, particularly in low- and middle-income countries, reflecting greater awareness and government support for safe transfusion practices. As healthcare systems strengthen blood safety standards, the need for accurate blood group typing to ensure compatibility and reduce transfusion-related risks continues to grow. The expanding use of blood transfusions in trauma care, oncology, prenatal medicine, and chronic blood disorders such as thalassemia and sickle cell disease further amplifies this demand, making reliable blood typing a critical component of modern healthcare.

Technological innovation also plays a pivotal role in driving blood group typing market growth. Advances in PCR-based assays, microarrays, and automated analyzers are improving the speed, precision, and cost-effectiveness of blood typing workflows. These innovations enhance accuracy in donor-recipient matching and reduce human error, supporting broader adoption across hospitals and blood banks. While challenges persist particularly a shortage of skilled laboratory personnel and limited infrastructure in developing regions ongoing investments in training, healthcare modernization, and public-private initiatives are expected to gradually overcome these barriers, fostering sustained market expansion.

Segment Analysis

The PCR-based and microarray technique segment leads the blood group typing market and is expected to maintain its dominance, thanks to its ability to provide genetic-level precision, resolve ambiguous serological results, and deliver faster turnaround times. These advanced molecular methods are increasingly adopted in clinical settings that demand high accuracy, gradually transforming traditional serology practices. Other emerging techniques, including massively parallel sequencing and assay-based methods, currently hold smaller market shares but show promise for specialized testing, comprehensive antigen profiling, and research applications as next-generation technologies mature.

In terms of test type, antibody screening accounts for the largest share, reflecting its central role in pregnancy testing, organ transplantation, and hospital "type and screen" procedures. By product type, consumables such as antisera and RBC reagents dominate due to consistent testing demand, while instruments and services provide complementary growth through equipment sales and maintenance. Among end users, blood banks lead the market, driven by high testing volumes during collection and distribution, followed by hospitals and clinical laboratories that rely on reliable blood typing for transfusions and patient management.

Request a sample report to access more segmental analysis: https://straitsresearch.com/report/blood-group-typing-market/request-sample

Regional Analysis

North America currently leads the global blood group typing market, supported by a well-established healthcare system, high transfusion volumes, and strong diagnostic infrastructure. The U.S. alone requires tens of thousands of red blood cell units daily, underscoring the region's immense demand for accurate and efficient blood typing. Mature reimbursement frameworks, widespread hospital adoption, and the presence of key diagnostic companies further fuel technological innovation and market penetration. Europe follows closely, driven by growing healthcare expenditure, robust R&D activity, and favorable policy support. Rising incidences of chronic diseases such as cancer and the increasing need for precise compatibility testing in surgical and transplant procedures make the U.K., France, and Germany key growth hubs in the region.

The Asia-Pacific region is expected to register the fastest growth, bolstered by rapid healthcare infrastructure expansion and strong governmental investment in countries like China, India, and Japan. Increasing transfusion needs driven by trauma, infectious disease prevalence, and chronic illness are accelerating adoption of modern typing technologies. Meanwhile, Latin America, the Middle East, and Africa are emerging as promising markets with growing public-private initiatives to strengthen blood safety programs. While infrastructure limitations and funding constraints remain challenges, rising awareness and healthcare modernization are expected to gradually unlock significant market potential across these regions.

List of key players in Blood Group Typing Market

Quotient Limited
Immucor Inc.
Merck KGaA
DIAGAST
The Novacyt Group
Agena Bioscience Inc.
BAG Diagnostics Gmbh
AXO Science
Grifols S.A.
Rapid Labs Limited
Buy full report: https://straitsresearch.com/buy-now/blood-group-typing-market

Conclusion

The global blood group typing market is on a strong upward trajectory, underpinned by growing demand for safe transfusions, expanding donor pools, and continuous technological advancement. While PCR-based and microarray techniques, antibody screening, and consumables currently lead the market, future shifts may witness more adoption of high-throughput sequencing and integrated diagnostic platforms. Regionally, North America and Europe remain strongholds, but the Asia-Pacific and emerging regions present the most promising growth avenues.

More Related Reports:

Blood Testing Market: https://straitsresearch.com/report/blood-testing-market

Blood Transfusion Market: https://straitsresearch.com/report/blood-transfusion-market

Cord Blood Banking Services Market: https://straitsresearch.com/report/cord-blood-banking-services-market

Blood Market: https://straitsresearch.com/report/blood-market

Blood Grouping Reagents Market: https://straitsresearch.com/report/blood-grouping-reagents-market

Contact Us

Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.

+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.

This release was published on openPR.